Next 10 |
home / stock / gsd:cc / gsd:cc news
Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), today announced financial results for its second quarter ended on January 31, 2024. Management Comments " This has been a truly transformative quarter fo...
Not for distribution to United States newswire services or for dissemination in the United States Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation...
Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced t...
Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, is pleased ...
Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced t...
Not for distribution to United States newswire services or for dissemination in the United States Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation...
Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, today announced ...
Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, is pleased ...
Luc Grégoire, current Director of Devonian, appointed as President and CEO, brings 30 years of financial capital markets, strategic and operational leadership David Baker transitions from board director with appointment as non-executive Chairman of the Board of Directors ...
Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXv: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, is pleased ...
News, Short Squeeze, Breakout and More Instantly...
Devonian Health Group Inc. Company Name:
GSD:CC Stock Symbol:
TSXVC Market:
Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), today announced financial results for its second quarter ended on January 31, 2024. Management Comments " This has been a truly transformative quarter fo...
Not for distribution to United States newswire services or for dissemination in the United States Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation...
Devonian Health Group Inc. (“ Devonian ” or the “ Corporation ”) ( TSXV: GSD; OTCQB: DVHGF ), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced t...